SBL
EVH icon

Sargent Bickham Lagudis’s Evolent Health EVH Stock Holding History

Sargent Bickham Lagudis’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-19
Closed – – 949
2020
Q4 		$0 Hold
19
– – ﹤0.01% 885
2020
Q3 		$0 Hold
19
– – ﹤0.01% 803
2020
Q2 		$0 Hold
19
– – ﹤0.01% 778
2020
Q1 		$0 Buy
+19
New +$170 ﹤0.01% 815

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Sargent Bickham Lagudis's EVH Position: Q1 2021 in Review

Sargent Bickham Lagudis sold out of Evolent Health (EVH) in Q1 2021, closing a stake of 19 shares.

Sargent Bickham Lagudis first reported a position in EVH in Q1 2020 and held it in 4 quarters. The position peaked at $0 in Q4 2020. 168 funds tracked by Wall St. Rank hold EVH as of Q1 2021.

  • Sargent Bickham Lagudis reported no remaining Evolent Health position as of Q1 2021 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 19 Evolent Health shares in Q1 2021.
  • Sargent Bickham Lagudis first reported a position in Evolent Health in Q1 2020 and held it in 4 quarters.
  • Sargent Bickham Lagudis's Evolent Health position peaked at $0 in Q4 2020.
  • 168 funds tracked by Wall St. Rank held Evolent Health as of Q1 2021.

Based on Sargent Bickham Lagudis's 13F filing for Q1 2021, filed 24 May 2021.